Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
Condition: Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma) Intervention: Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Chronic Leukemia | Chronic Lymphocytic Leukemia | Japan Health | Leukemia | Lymphoma | Marketing | Research | Study